Published on : Sep 10, 2015
International Business Machines Corporation (IBM) on Thursday announced the appointment of a new general manager for its Watson Health division, establishment of an international headquarters for its supercomputer, release of two new products, and several upcoming partnerships.
Deborah DiSanzo, former chief executive officer of Philips Healthcare was assigned to her new role of general manager of Watson Health. She was charged with the responsibility of developing the cognitive computing division that was set up by IBM in April. DiSanzo joins IBM at a time when there is a massive buzz surrounding Watson.
What was initially considered to be a rather surprising partnership with Apple, is now resulting in Watson’s integration with both HealthKit and ResearchKit platforms for Care Manager, which allows for personalized tools of patient engagement.
The company on Thursday also launched IBM Watson Health Cloud for Life Sciences Compliance, which is a service designed to allow customers of biomed to transfer more of the drug life cycle on to the cloud.
DiSanzo will be working at the new global headquarters for IBM Watson Health in Cambridge in Massachusetts, which is projected to act as a hub for most of the new collaborations and alliances announced by IBM on Thursday.
IBM will be working alongside Columbia University, Boston Children’s Hospital, Teva Pharmaceuticals, Sage Bionetworks, and ICON plc on numerous initiatives such as pediatrics, chronic disease management, population health, and clinical research.
There is a certain pattern that can be determined from IBM’s initiatives to ramp up Watson for health care providers. Big Blue usually clusters many significant announcements together.
In fact, the partners that were announced by IBM on Thursday are part of a growing list of pharma and health care companies that will be working with Watson Health such as MD Anderson, CVS Health, Memorial Sloan Kettering, Medtronic, and Yale University, among others.